Surgery versus combined therapies for cancer of the anterior floor of the mouth

C. Grandi, F. Chiesa, M. Cervia, L. Sala, P. R. Barbano, R. Molinari

Research output: Contribution to journalArticlepeer-review


We report the results of treatment in a consecutive series of 75 patients operated on at the Istituto Nazionale Tumori of Milan, from January 1965 to December 1979, for cancer of the anterior floor of the mouth. Most of the tumors were advanced: 39 were treated with simple resection, and 36 underwent combined treatment, consisting of surgery associated with either chemotherapy or surgery. Three- and five-year observed survival rates of the whole series were good (41% and 25%, respectively), considering the tumor stage of these patients, but the determined survival rates were particularly high (56% and 46%, respectively). No real advantage was found in the use of multiple planned sequential therapies over surgery alone, and deaths from intercurrent diseases seemed to be more frequent in the patients who underwent combined therapies. We conclude that for patients in poor general condition, such as those with carcinomas of the anterior floor of the mouth, aggressive and complex treatments should be considered with caution in controlled clinical trials.

Original languageEnglish
Pages (from-to)653-659
Number of pages7
JournalHead and Neck
Issue number2
Publication statusPublished - 1983

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Surgery versus combined therapies for cancer of the anterior floor of the mouth'. Together they form a unique fingerprint.

Cite this